Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Product: | Budesonide Te Arai |
| Active Ingredient: | Budesonide 3mg |
| Dosage Form: | Modified release capsule |
| New Zealand Sponsor: | Te Arai BioFarma Limited |
| Manufacturer: | Laboratorios Liconsa SA, Guadalajara, Spain |
Dated this 19th day of May 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).